Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Single Cell Multi-Omic Analysis of Neoplastic Plasma Cells across the Disease Spectrum Identifies Novel Pathobiologic Mediators and Potential Therapeutic Targets in Multiple Myeloma (MM)

Luz Yurany Moreno Rueda, Keiko Akagi, Amishi U. Vora, Hans C. Lee, Krina K. Patel, Pei Lin, Bo Jiang, Yang Song, Maura L. Gillison, Sheeba K. Thomas, Donna M. Weber, Lixia Diao, Jing Wang, Elisabet E. Manasanch, David E. Symer, Robert Z. Orlowski

Blood (2023) 142 (Supplement 1): 752.

https://doi.org/10.1182/blood-2023-188016

Published: 2023

Journal Articles

Safety and Efficacy of a-319 (a CD3xCD19 T cell engager) in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Wei Ping Liu, Bo Jiang, Yue Rong Shuang, Xing Zhao, Xuan Fan Zhong, Ying Tan, Guo Jian Yu, Sheng Jie Xue, Wu Zhong Shen, Gui Yun Tu, Zheng Yang, Han Yang Chen, Jason Xu, Shui Liu, Xiao Qiang Qiang Yan, Jun Zhu, Yu Qin Song

Blood (2023) 142 (Supplement 1): 6158.

https://doi.org/10.1182/blood-2023-188071

Published: 2023

Journal Articles

Distance to Care Predicts Clinical Trial Enrollment on COG ALL Clinical Trials: A Report from the Children's Oncology Group

Lena E Winestone, Sumit Gupta, Jeannette Sample, David Van Riper, Katherine Knowles, Zhiguo (Bruce) Chen, Bo Jiang, Maria C Velez, Mignon L. Loh, Philip J. Lupo, Naomi J Winick, Erin Marcotte

Blood (2023) 142 (Supplement 1): 2392.

https://doi.org/10.1182/blood-2023-182477

Published: 2023

Journal Articles

A Phase I/IIa Study of Lemzoparlimab, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Initial Phase I Results

Junyuan Qi, MD, Jian Li, MD, Bin Jiang, MD, Bo Jiang, MD, Hongzhong Liu, MD, Xinxin Cao, MD, Meixiang Zhang, MD, Yuan Meng, MD, Xiaoyu MA, Yingmin Jia, Jiyuan Guo, Yanni Zhang, Wei Huang, Jianxiang Wang, MD

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-134391

Published: 2020

Journal Articles

Preliminary Results from a Phase I, First-in-Human Study of YY-20394, a Highly Selective and Highly Potent PI3Kδ Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies

Junyuan Qi, PhD, Yuqin Song, MD PhD, Bo Jiang, PhD, Jianyong Li, PhD, Meifeng Tu, PhD, Lingyan Ping, MD PhD, Zengjun Li, PhD, Wei Xu, MD PhD, Huayuan Zhu, MD PhD, Jun Zhu, MD PhD, Hanying Bao, MD PhD, Zusheng Xu, PhD, Lugui Qiu, MD PhD

Blood (2018) 132 (Supplement 1): 5332.

https://doi.org/10.1182/blood-2018-99-110585

Published: 2018

Journal Articles

Use Of Novel Oral Anticoagulants For Treatment Of Venous Thromboembolism (VTE) In Patients With Malignancy: Meta-Analysis Of Randomized Controlled Trials

Bo Jiang, MD, Qasim Malik, MD, Louis Romel Crevecoeur, MD

Blood (2013) 122 (21): 1150.

https://doi.org/10.1182/blood.V122.21.1150.1150

Published: 2013

Journal Articles

The Therapeutic Effect of Umbilical Mesenchymal Stem Cells Injected Directly Into Medullary Cavity of Ilium to Treat Refractory Aplastic Anemia and Bone Marrow Fibrosis,

Zhuanzhen Zheng, MD, PhD, Zhenhua Qiao, MD, Wenliang Chen, MD, Rong Gong, MD, Yalin Wang, MD, Lianrong Xu, MD, PhD, Yanping Ma, MD, PhD, Lihong Hou, MD, PhD, Li Zhang, MD, PhD, Yujin Lu, Bo Jiang, MD, Guoxia Li, Chunxia Dong, MD, PhD

Blood (2011) 118 (21): 3226.

https://doi.org/10.1182/blood.V118.21.3226.3226

Published: 2011

Journal Articles

Using Auto Dendritic Cells Accompanied with CIK Plus Chemotherapy As Consolidation Treatment for 59 Patients with Acute Leukemia

Blood (2011) 118 (21): 4923.

https://doi.org/10.1182/blood.V118.21.4923.4923

Published: 2011

Journal Articles

In GM-CSF Restrain Mitochondria Pathway Apoptosis NF-kB Is Not the Only Way.

Bo Jiang, Ri Zhang, De Pei Wu

Blood (2006) 108 (11): 4226.

https://doi.org/10.1182/blood.V108.11.4226.4226

Published: 2006

NARROW

Single Cell Multi-Omic Analysis of Neoplastic Plasma Cells across the Disease Spectrum Identifies Novel Pathobiologic Mediators and Potential Therapeutic Targets in Multiple Myeloma (MM)

Safety and Efficacy of a-319 (a CD3xCD19 T cell engager) in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Distance to Care Predicts Clinical Trial Enrollment on COG ALL Clinical Trials: A Report from the Children's Oncology Group

A Phase I/IIa Study of Lemzoparlimab, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Initial Phase I Results

Preliminary Results from a Phase I, First-in-Human Study of YY-20394, a Highly Selective and Highly Potent PI3Kδ Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies

Use Of Novel Oral Anticoagulants For Treatment Of Venous Thromboembolism (VTE) In Patients With Malignancy: Meta-Analysis Of Randomized Controlled Trials

The Therapeutic Effect of Umbilical Mesenchymal Stem Cells Injected Directly Into Medullary Cavity of Ilium to Treat Refractory Aplastic Anemia and Bone Marrow Fibrosis,

Using Auto Dendritic Cells Accompanied with CIK Plus Chemotherapy As Consolidation Treatment for 59 Patients with Acute Leukemia

In GM-CSF Restrain Mitochondria Pathway Apoptosis NF-kB Is Not the Only Way.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only